Crowdly
Додати до Chrome
VaccinesRUs is a biotech start up. Clinical trials of its product will start nex...
✅ Перевірена відповідь на це питання доступна нижче. Наші рішення, перевірені спільнотою, допомагають краще зрозуміти матеріал.
VaccinesRUs is a biotech start up. Clinical trials of its product will start next year and if trials are successful, authorisation to market their product will be given for the following year (year 2). Analysts expect VaccinesRUs to start paying dividends in five-years’ time, and the first dividend is expected to be 25p per share. Dividends are predicted to grow at 3% per year. If the discount rate is 8%, what is today’s share price?
0%
0%
0%
0%
❌